Advertisement
Screener

10x Genomics, Inc. (TXG) Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss

2.5 / 5 stars · 36/71 Roast Me

10x Genomics, Inc. Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss

10x Genomics, Inc. (TXG) reported Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-13.

Financial Statements › Income Statement › Other Income

us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2026-02-13

  • 10x Genomics, Inc. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2025-12-31 was $0.00.
  • 10x Genomics, Inc. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2025-09-30 was $0.00.
  • 10x Genomics, Inc. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2024-12-31 was $0.00.
  • 10x Genomics, Inc. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2024-09-30 was -$2.00K.
  • 10x Genomics, Inc. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2025 was $0.00.
  • 10x Genomics, Inc. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2024 was -$3.00K.
  • 10x Genomics, Inc. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2023 was -$1.72M.
  • 10x Genomics, Inc. marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2022 was $0.00.
Period endMarketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 3 monthMarketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 monthMarketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 9 monthMarketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 12 month
2025-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$0.00
derived: sum of 2 quarters · filed 2026-02-13
$0.00
10-K · filed 2026-02-13
2025-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$0.00
10-Q · filed 2025-11-07
2025-06-30$0.00
10-Q · filed 2025-08-08
2024-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
-$2.00K
derived: sum of 2 quarters · filed 2026-02-13
-$3.00K
derived: sum of 3 quarters · filed 2026-02-13
-$3.00K
10-K · filed 2026-02-13
2024-09-30-$2.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
-$3.00K
derived: sum of 2 quarters · filed 2025-11-07
-$3.00K
10-Q · filed 2025-11-07
-$6.00K
derived: sum of 4 quarters · filed 2026-02-13
2024-06-30-$1.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
-$1.00K
10-Q · filed 2025-08-08
-$4.00K
derived: sum of 3 quarters · filed 2026-02-13
-$4.00K
derived: sum of 4 quarters · filed 2026-02-13
2024-03-31$0.00
10-Q · filed 2024-04-30
-$3.00K
derived: sum of 2 quarters · filed 2026-02-13
-$3.00K
derived: sum of 3 quarters · filed 2026-02-13
-$3.00K
derived: sum of 4 quarters · filed 2026-02-13
2023-12-31-$3.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
-$3.00K
derived: sum of 2 quarters · filed 2026-02-13
-$3.00K
derived: sum of 3 quarters · filed 2026-02-13
-$1.72M
10-K · filed 2026-02-13
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29
$0.00
derived: sum of 2 quarters · filed 2024-10-29
-$1.72M
10-Q · filed 2024-10-29
-$1.72M
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$1.72M
10-Q · filed 2024-08-08
-$1.72M
derived: sum of 3 quarters · filed 2025-02-13
-$1.72M
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31-$1.72M
10-Q · filed 2024-04-30
-$1.72M
derived: sum of 2 quarters · filed 2025-02-13
-$1.72M
derived: sum of 3 quarters · filed 2025-02-13
2022-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
$0.00
derived: sum of 2 quarters · filed 2025-02-13
$0.00
10-K · filed 2025-02-13
2022-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
$0.00
10-Q · filed 2023-11-03
2022-06-30$0.00
10-Q · filed 2023-08-04
2021-12-31$0.00
10-K · filed 2024-02-15